Insider Transactions Reported by 22 Insiders of Climb Bio, Inc.

Symbol
CLYM on Nasdaq
Location
Wellesley Hills, MA

Insiders trading volume in the past year

Climb Bio, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
AI ETI LLC 10%+ Owner $62,617,500 12 Aug 2021
RA CAPITAL MANAGEMENT, L.P. Director, 10%+ Owner $9,713,469 +$754,737 +8.4% 11 Dec 2025
Aoife Brennan President and CEO, Director $2,042,709 -$25,154 -1.2% 27 Jun 2025
Brett Kaplan Chief Operating Officer $618,450 13 Jan 2025
Stephen Basil Thomas Director $444,159 07 Aug 2025
Valerie Morisset Evp, R&D And Cso $249,910 19 Jul 2024
Emily Pimblett SVP, Finance & CAO $63,821 -$3,111 -4.6% 18 Jun 2025
Susan ALTSCHULLER Chief Financial Officer 01 Oct 2025
DOUGLAS E. WILLIAMS Director 04 Jun 2025
Alexander Cumbo Director 04 Jun 2025
Kimberlee C. Drapkin Director 04 Jun 2025
Judith Dunn Director 04 Jun 2025
Andrew David Levin Director 04 Jun 2025
Cindy Driscoll Senior Vice President, Finance 17 Jun 2025
Perrin Megan Wilson Chief Business Officer 17 Jun 2025
Liam Ratcliffe Director 26 Jun 2024
Adam Joseph Rosenberg Director 26 Jun 2024
Erin Lavelle Coo & Cfo 31 Oct 2022
Robert Azelby President & CEO, Director 31 Oct 2022
Simon Tate Director 26 Jun 2024
LEONE D. PATTERSON Director 19 May 2022
James Bucher EVP and General Counsel 31 Oct 2022

Recent Insider Transactions by Companies or Individuals for Climb Bio, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.